全文获取类型
收费全文 | 1884篇 |
免费 | 104篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 40篇 |
儿科学 | 69篇 |
妇产科学 | 23篇 |
基础医学 | 373篇 |
口腔科学 | 56篇 |
临床医学 | 158篇 |
内科学 | 319篇 |
皮肤病学 | 75篇 |
神经病学 | 129篇 |
特种医学 | 227篇 |
外科学 | 193篇 |
综合类 | 19篇 |
一般理论 | 5篇 |
预防医学 | 111篇 |
眼科学 | 20篇 |
药学 | 99篇 |
中国医学 | 8篇 |
肿瘤学 | 72篇 |
出版年
2021年 | 25篇 |
2020年 | 15篇 |
2019年 | 20篇 |
2018年 | 28篇 |
2017年 | 17篇 |
2016年 | 25篇 |
2015年 | 33篇 |
2014年 | 44篇 |
2013年 | 78篇 |
2012年 | 80篇 |
2011年 | 95篇 |
2010年 | 41篇 |
2009年 | 39篇 |
2008年 | 75篇 |
2007年 | 74篇 |
2006年 | 75篇 |
2005年 | 71篇 |
2004年 | 58篇 |
2003年 | 61篇 |
2002年 | 63篇 |
2001年 | 24篇 |
2000年 | 18篇 |
1999年 | 19篇 |
1998年 | 20篇 |
1997年 | 21篇 |
1996年 | 17篇 |
1995年 | 20篇 |
1994年 | 17篇 |
1993年 | 11篇 |
1992年 | 20篇 |
1991年 | 13篇 |
1990年 | 19篇 |
1989年 | 13篇 |
1988年 | 22篇 |
1987年 | 11篇 |
1986年 | 18篇 |
1985年 | 17篇 |
1983年 | 20篇 |
1982年 | 14篇 |
1980年 | 12篇 |
1979年 | 22篇 |
1936年 | 11篇 |
1932年 | 21篇 |
1930年 | 12篇 |
1929年 | 11篇 |
1928年 | 13篇 |
1924年 | 14篇 |
1923年 | 11篇 |
1922年 | 15篇 |
1884年 | 15篇 |
排序方式: 共有1996条查询结果,搜索用时 15 毫秒
1.
Dr. Gustav Pickroth 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》1949,262(5-6):385-389
Zusammenfassung Als Beitrag zur Frage eines Überganges der Cystenmamma in Carcinom werden in der vorliegenden Arbeit 381 Fälle mit klinisch einwandfrei cystischen Veränderungen der Brustdrüse aus der Chirurgischen Universitätsklinik Jena der Jahre 1920–1946 zusammengestellt unddie histologisch bewiesenen Fälle (169) zu Besprechungen herangezogen. Dabei zeigte sich, daßin 7,1% der Fälle die Mastopathia cystica einenKrebs oder krebsartige Veränderungen aufweist. Nach diesem Häufigkeitsverhältnis können wir diese Erkrankung nicht als Präcarcinomatose oder als Erkrankung, auf deren Boden sich ein Krebs prädisponiert entwickelt, ansprechen. Die Tatsache aber allein der Krebsentwicklung mahnt zur Vorsicht und weist die damit sich ergebende Behandlung, die kurz aufgezeichnet wird. Nachuntersuchungen und Anfragen bestätigen das gefundene Ergebnis. 相似文献
2.
Dr. Gustav Paul 《Archives of dermatological research》1900,52(1):3-28
Ohne ZusammenfassungHiezu Taf. I–V. 相似文献
3.
Ohne ZusammenfassungHierzu Taf. I–III.Anmerkung des Herausgebers. Diese Abhandlung ist vor dem Erscheinen der neuesten Schrift des Herrn v. Luschka über den Schlundkopf eingesendet worden. 相似文献
4.
Ohne Zusammenfassung 相似文献
5.
Dr. Gustav Behrend 《Virchows Archiv : an international journal of pathology》1872,55(3-4):538-538
Ohne Zusammenfassung 相似文献
6.
Paul S. Malchesky Rolf Bambauer Takashi Horiuchi† DAndre Kaplan‡ Yutaka Sakurada§ Gustav Samuelsson& 《Artificial organs》1995,19(4):315-323
Abstract: The developments in apheresis techniques and their clinical applications world-wide are technologically driven. In the past, apheresis survey statistics have highlighted both the differences by region in clinical practice and in the types of technologies utilized. Such differences have provided a basis for the scientific and clinical assessments of these apheresis technologies and their clinical outcomes and have stimulated the marketing and business development of new technologies world-wide. A review of the regional practices and technologies utilized provides a perspective on the future role of apheresis and its developments in clinical practice. While technology is a driving force for the development of new techniques for clinical practice, it is not the only market force. For technology introduction, several other important issues need to be considered. Regulations at the local and, most importantly, the federal level impact the timing for new technology introduction. Reimbursement by healthcare payers is critically important from the initiation of the development of a technology through its clinical use. Clinical trials are critically important to show the safety and clinical- and cost-effectiveness of the technology in order for payers to provide reimbursement for its use, but these trials are sometimes long and costly. Research funding availability at the governmental and commercial levels critically impacts new technology investigation and its introduction. Apheresis technology developments offer new hopes and promises for the clinical team; however, their development, introduction, and utilization will be influenced by the prevailing market forces. 相似文献
7.
Laryngomalacia: a cause for early near miss for SIDS 总被引:1,自引:0,他引:1
Y Sivan J Ben-Ari T M Schonfeld 《International journal of pediatric otorhinolaryngology》1991,21(1):59-64
Six infants had recurrent apnea of infancy episodes (near miss sudden infant death syndrome) during their neonatal period. Physical examination and laboratory investigation were normal. Polygraphic sleep monitoring revealed recurrent obstructive sleep apnea. These infants underwent fiberoptic endoscopy which showed that airway obstruction occurred at the laryngeal orifice as a result of laryngomalacia. It is suggested that laryngomalacia may be a cause for early apnea of infancy. 相似文献
8.
Expression of cell-matrix molecules and integrin receptors in human liver grafts during chronic rejection 总被引:1,自引:0,他引:1
Ken Hoshino Bjorn Nashan Gustav Steinhoff Rudolf Pichlmayr K. Hoshino 《Transplant international》1994,7(S1):637-640
Abstract The inflammatory response of immune cells to target cells and cell-matrix molecules is regulated by several receptor-ligand molecules. As fibrosis develops in ongoing chronic rejection after liver transplantation, it is of interest to analyze patterns of integrin receptors and cell-matrix molecules in order to study the relation between immune cells and the stromal and parenchymal cells. In the present study, we demonstrated the expression of these molecules in chronic rejected human liver grafts using immunohistochemical techniques. The results showed a differential expression and induction of integrin receptors and cell-matrix molecules on resident liver cells, especially on sinusoids, reflecting a state of chronic inflammation and a specific interaction between integrin receptors and cell-matrix molecules. The patterns of induced integrin receptors on graft-infiltrating cells was closely related to the local production of cell-matrix molecules and reflected the final sequence of a stepwise progress of the inflammatory reaction. 相似文献
9.
Dependence of metabolic and structural heterogeneity of cholesterol ester-rich very low density lipoproteins on the duration of cholesterol feeding in rabbits. 总被引:3,自引:2,他引:1
下载免费PDF全文
![点击此处可从《The Journal of clinical investigation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Cholesterol ester-rich (CER) VLDL accumulate rapidly in the plasma of rabbits fed cholesterol-enriched diets. However, the major loci of enhanced synthesis of subfractions of CER-VLDL, their interaction with macrophages, and their relative contribution to atherogenesis have not yet been elucidated. To determine whether anabolism is hepatic or intestinal, subfractions of CER-VLDL were characterized at selected intervals from day 0 to 60 of cholesterol feeding. Rate zonal ultracentrifugation of CER-VLDL from rabbits fed cholesterol for 4 and 60 d demonstrated an early increase of the proportion of cholesterol carried in the intestinally-derived fraction (designated as Fx-I) of VLDL compared with that in hepatically-derived particles (Fx-H). Quantification by size exclusion HPLC also demonstrated that Fx-I was a prominent CER-VLDL component at day 4, while Fx-H particles became increasingly prominent with further cholesterol feeding. At both 4 and 60 d Fx-I stimulated cholesterol esterification and intracellular cholesterol content in macrophages more than the corresponding Fx-H did. In fact, Fx-H harvested at 4 d produced no cholesterol ester deposition. In contrast, Fx-H harvested at 60 d markedly stimulated cholesterol esterification and intracellular cholesterol content. Thus, both compositional and metabolic characteristics of CER-VLDL changed as a function of the duration cholesterol feeding. 相似文献
10.
P. H. Cox J. Verweij M. Pillay G. Stoter D. Schonfeld 《European journal of nuclear medicine and molecular imaging》1988,14(1):50-52
111In-antimyosin monoclonal antibody complex passes through damaged myocardial cell membranes and binds to the intracellular myosin. Normal myocardial and other muscle cells show no uptake.Rhabdomyosarcoma and Leiomyosarcoma cells also contain intracellular myosin.and the cell membrane permeability is greater than normal. Significant uptake of 111In-antimyosin was observed in patient with Leiomyosarcoma and Rhabdomyosarcoma suggesting that the reagent has a potential for the in vivo detection of these tumour types. Tumour to background ratios of 10:1 were measured in one case and in view of the fact that the site of accumulation is intracellular, antimyosin may have a potential as a carrier for therapeutic agents. 相似文献